Mass spectral and NMR spectral data of two new designer drugs with an α-aminophenone structure: 4′-Methyl-α-pyrrolidinohexanophenone and 4′-methyl-α-pyrrolidinobutyrophenone

Forensic Science International

Volumn 169, Issue 1, 2007, Pages 32-42

  Westphal, Folker ^a   Junge, Thomas ^a   Rösner, Peter ^b   Fritschi, Giselher ^c   Klein, B ^c   Girreser, Ulrich ^b  

^a Sachgebiet Betäubungsmittel Toxikologie   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Hessisches Landeskriminalamt   (Germany)

Author keywords

Designer drugs; Mass spectral data; NMR spectroscopy; Product ion mass spectrometry; Structure elucidation; Pyrrolidinophenone substructure

Indexed keywords

4' METHYL ALPHA PYRROLIDINOHEXANOPHENONE; 4' METYL ALPHA PYRROLIDINOBUTYPHENONE; DESIGNER DRUG; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 34248140784     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2006.07.024     Document Type: Article

References (28)

1. Kaddatz R., and Pötzsch E. Pharmakologische Eigenschaften eines neuen Analeptikums 1-Phenyl-2-pyrrolidino-pentan (Pharmacological properties of the new analeptic 1-phenyl-2-pyrrolidino-pentane). Arzneim.-Forschung (1957) 344-349
2. Zhingel K.Y., et al. 2-Methylamino-1-phenylpropane-1-one (Jeff). J. Forensic Sci. 36 3 (1991) 8-16
3. Friel P.N., Logan B.K., and Fligner C.L. Three fatal drug overdoses involving bupropion. J. Anal. Toxicol. 17 (1993) 436-437
4. Dal Cason T.A. The characterization of some 3,4-methylenedioxycathinone (MDCATH) homologs. Forensic Sci. Int. 87 (1997) 9-53
5. Stille G., Ackermann H., Eichenberger E., and Lauener H. Vergleichende pharmakologische Untersuchung eines neuen Stimulans, 1-p-Tolyl-1-oxo-2-pyrrolidino-n-pentan (Comparative pharmacological study of the new stimulant 1-p-tolyl-1-oxo-2-pyrrolidino-n-pentane). Arzneim.-Forschung (1963) 871-877
6. Heffe W. Die Stevens-Umlagerung von Allyl-phenacyl-ammoniumsalzen (The Stevens rearrangement of allyl-phenacyl-ammonium salts). Helv. Chim. Acta 47 (1964) 1289
7. Shin H.-S., Shin Y.-S.O., Lee S., and Park B.-B. Detection and identification of pyrovalerone and its hydroxylated metabolite in rat. J. Anal. Toxicol. 20 (1996) 568-572
8. Lho D.-S., Lee J., Kim S., Park J., and Shin H.-S. Identification of a pyrovalerone metabolite in the rat by gas chromatography-mass spectrometry and determination of pyrovalerone by gas chromatography-nitrogen-phosporous detection. J. Chromatogr. B 687 (1996) 253-259
9. Springer D., Peters F.T., Fritschi G., and Maurer H.H. Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry. J. Chromatogr. B 773 (2002) 25-33
10. Springer D., Peters F.T., Fritschi G., and Maurer H.H. New designer drug 4′-methyl-α-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. J Chromatogr. B 789 (2003) 79-91
11. Springer D., Fritschi G., and Maurer H.H. Metabolism and toxicological detection of the new designer drug 4′-methoxy-α-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. J. Chromatogr. B 793 (2003) 331-342
12. Springer D., Fritschi G., and Maurer H.H. Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry. J. Chromatogr. B 793 (2003) 377-388
13. Springer D., Fritschi G., and Maurer H.H. Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-α-pyrrolidino-propiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry. J. Chromatogr. B 796 (2003) 253-266
14. Fritschi G. New designer drugs in the Federal Republic of Germany (BRD). In: Pragst F., and Aderjan R. (Eds). XII GTFCh-Symposium in Mosbach (2001), Verlag Dr. Dieter Heppenheim, Heppenheim 119-129
15. 10N+ immonium ions. J. Mass Spectrom. 31 (1996) 1047-1053
16. Rösner P., and Junge Th. Structure elucidation of new designer drugs by daughter ion mass spectroscopy. In: Pragst F., and Aderjan R. (Eds). XII GTFCh-Symposium in Mosbach (2001), Verlag Dr. Dieter Heppenheim, Heppenheim 130-142
17. P. Rösner, F. Westphal, Th. Junge, Strukturaufklärung von Designerdrogen mittels Tochterionenspektroskopie (Structure elucidation of designer drugs by daughter ion mass spectrometry). GTFCh Workshop in Hamburg 2004.
18. Peters F.T., Meyer M.R., Fritschi G., and Maurer H.H. Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinobutyrophenone (MPBP) in urine using gas chromatography-mass spectrometry. J. Chromatogr. B 824 (2005) 81-91
19. Dawson P.H., and Sun W.-F. A round robin on the reproducibility of standard operating conditions for the acquisition of library MS/MS spectra using triple quadrupols. Int. J. Mass Spectrom. Ion Proc. 55 (1984) 155-170
20. Fritschi G., Klein B., and Rösner P. Neue, bisher auf dem illegalen Drogenmarkt nicht in Erscheinung getretene Amphetaminderivate mit Propiophenon-Partialstruktur (New amphetamine derivatives with a propiophenone-substructure on the illegal market). Arch. f. Kriminol. 200 1-2 (1997) 8-16
21. Klein B., Thielert K., and Fritschi G. Amphetaminderivate mit einer Propiophenon-Teilstruktur: MS- und IR-Daten (Amphetamine derivatives with a propiophenone-substructure: MS- and IR-data). Toxichem Krimtech 66 (1999) 129-153
22. Rösner P., and Junge Th. N-Methyl-1-(3,4-methylendioxyphenyl)-2-butanamin, ein Vertreter einer neuen Klasse von Designerdrogen. Toxichem Krimtech 61 2 (1994) 32-38
23. Rösner P., and Junge Th. N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine, a representative of a new class of street drugs. Microgram 27 12 (1994) 411-418
24. Borth S., Hänsel W., Rösner P., and Junge Th. Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS. Forensic Sci. Int. 114 (2000) 139-153
25. Borth S., Hänsel W., Rösner P., and Junge Th. Regioisomeric differentiation of 2,3- and 3,4-methylenedioxy ring-substituted phenylalkylamines by gas chromatography/tandem mass spectrometry. J. Mass Spectrom. 35 (2000) 705-710
26. Rösner P., Zechlin L., and Junge Th. N-Ethyl-2-(3,4-methylendioxyphenyl)-propan-1-amin eine neue Designerdroge mit der Struktur eines beta-isomeren MDE (N-Ethyl-2-(3,4-methylenedioxyphenyl)-propane-1-amine-a new designer drug with a structure of a beta-isomeric MDE). Toxichem Krimtech 70 2 (2003) 82-86
27. Karni A., and Mandelbaum A. The even electron rule. Org. Mass Spectrom. 15 (1980) 53-64
28. Th. Junge, P. Rösner, F. Westphal, Daughter ion mass spectra of important organic ions, a free printed version can be ordered from the authors.